Howard Lutnick

Lutnick’s central macro call is that U.S. GDP growth will show “fives” early in 2026 and “sixes” if a new Fed chair cuts rates. On a $30 trillion economy, 5% means $1.5 trillion of growth; he points to $18 trillion of pledged investment, 30 newly launched construction projects, and factories moving from spreadsheets into the ground. A shutdown-related accounting distortion could subtract 1.5 points from fourth-quarter GDP, masking what he says would otherwise be roughly 4% growth.

The administration’s tariff thesis starts with ownership, not the monthly trade balance: America moved from owning $148 billion more of the world in 1985 to the world owning $26 trillion more of America in 2024. Lutnick’s “two islands” analogy says the inventor eventually works for the producer if it continually exports its money and the producer reinvests those dollars in the inventor’s assets. The proposed correction is blunt: “Build it here, sell it here,” or pay for access to the U.S. market.

Japan is Lutnick’s model for converting tariff leverage into American productive assets. A threatened 25% auto tariff became 15% alongside $550 billion of Japanese financing for U.S.-selected, cash-generating projects: cash is split 50/50 until Japan recovers principal and interest, then 90/10 in America’s favor. His illustrative nuclear-project math has both sides receiving roughly $650 billion before the residual split changes.

The investable industrial-policy thesis is that cheap imported components conceal catastrophic single-point dependencies. Lutnick cites U.S. steel blast furnaces falling from 40 to 10, Chinese steel near $250 per metric ton against roughly $700 domestically, and a $20 magnet capable of immobilizing a $30,000 car. His conclusion is categorical: the U.S. must retain domestic capacity in steel, aluminum, copper, semiconductors, pharmaceuticals, and critical inputs.

Pharmaceutical repricing shows how the administration intends to pair market access with an explicit threat. Lutnick says drugmakers historically collected 75% of revenue and effectively all profit in America—illustratively charging $1,000 here and $175 in Europe—so Commerce offered tariff relief only for most-favored-nation pricing and reshoring. He credits that “hammer” with putting Ozempic and Mounjaro at $149 through Medicare and Medicaid, a Merck drug at zero, and $25-$35 billion in annual savings.

Semiconductor policy now seeks either domestic capacity or taxpayer participation in the upside. Lutnick says Commerce replaced a roughly $6 billion TSMC subsidy approach; the transcript gives the earlier build as $16 billion in one passage and $60 billion in another, while his later stated commitment is $165 billion after an additional $100 billion of construction, potentially higher. Separately, Nvidia can export H200s after U.S. testing and licensing while paying a 25% tariff, and the government converted prior Intel support into a 10% ownership stake.

The fiscal bull case combines tariff revenue, fraud recovery, government equity, and faster growth—but every large number remains an administration forecast. Lutnick puts current tariffs at $500 billion annually and says they could reach $1 trillion; he estimates perhaps $1 trillion in annual fraud through cross-agency data matching. “Imagine if you grow 6%”: his intended destination is lower deficits and taxes while preserving Social Security, not reducing benefits.

🔗 Original source & video: Howard Lutnick: How America Can Hit 6% GDP Growth in 2026